AICAR 是AMPK活化剂,可作用于急性淋巴细胞白血病。
AICAR is a cell permeable activator of AMP-activated protein kinase (AMPK), a metabolic master regulator that is activated in times of reduced energy availability (high cellular AMP:ATP ratios) and serves to inhibit anabolic processes. In vivo, pharmacologic activation of AMPK with AICAR mimics exercise and triggers insulin-independent glucose uptake by skeletal muscle.
0.9% NaCl
2.5 mM
50 mg/kg 腹腔内注射
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Corton JM, et al. Eur J Biochem, 1995, 229(2), 558-565.
[2] Robert G, et al. PLoS One, 2009, 4(11), e7889.
[3] Fabian TC, et al. Surgery, 1996, 119(3), 302-315.
[4] Giri et al (2008) The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: Implication for Krabbe disease. J.Neurochem. 105 1820.
[5] Wu et al (2011) AICAR, a small chemical molecule, primes osteogenic differentiation of adult mesenchymal stem cells. Int.J.Artif.Organs. 34 1128.
[6] Kanazawa et al (2007) Adiponectin and AMP kinase activator stimulate proliferation, differentiation and mineralization of osteoblastic MC3T3-EI cells. BMC Cell Biol. 8 51.
分子式 C9H14N4O5 |
分子量 258.23 |
CAS号 2627-69-2 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 75 mM |
Water 75 mM |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00004314 | Lesch-Nyhan Syndrome | Drug: aminomidazole carboxamide riboside | National Center for Research Resources (NCRR)|University of California, San Diego|Office of Rare Diseases (ORD) | Phase 2 | 1996-02-01 | 2005-06-23 |
NCT00168519 | Diabetes Mellitus, Type 2 | Drug: nitroprusside, pentalong, imdur, AICAR, isoptin | Baker Heart Research Institute|National Health and Medical Research Council, Australia|Hoffmann-La Roche|Diabetes Australia | 2002-10-01 | 2009-12-14 | |
NCT01246778 | Cardiotoxicity|Ischemia|Heart Failure | Radboud University | 2010-11-01 | 2014-04-30 | ||
NCT02322073 | Obesity|Inflammation|Kidney Disease|Liver Disease|Metabolic Syndrome | Procedure: Laparoscopic surgery | G枚teborg University | 2014-12-01 | 2017-02-01 | |
NCT01193959 | Non-small Cell Lung Cancer (NSCLC) | Istituto Clinico Humanitas | 2010-09-01 | 2010-10-11 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们